Literature DB >> 31591487

Pharmacological closure of the patent ductus arteriosus: when treatment still makes sense.

Maria Gillam-Krakauer1, James I Hagadorn2,3, Jeff Reese4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31591487      PMCID： PMC7055580          DOI： 10.1038/s41372-019-0518-3

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   3.225


× No keyword cloud information.
  1 in total

Review 1.  Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Prakeshkumar S Shah
Journal:  Cochrane Database Syst Rev       Date:  2018-04-06
  1 in total
  5 in total

Review 1.  Patent Ductus Arteriosus of the Preterm Infant.

Authors:  Shannon E G Hamrick; Hannes Sallmon; Allison T Rose; Diego Porras; Elaine L Shelton; Jeff Reese; Georg Hansmann
Journal:  Pediatrics       Date:  2020-11       Impact factor: 7.124

2.  Outcomes in infants < 29 weeks of gestation following single-dose prophylactic indomethacin.

Authors:  Jeff Reese; Nathalie L Maitre; Maria Gillam-Krakauer; James C Slaughter; Robert B Cotton; Blaine E Robinson
Journal:  J Perinatol       Date:  2020-09-18       Impact factor: 2.521

Review 3.  Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants.

Authors:  Hannes Sallmon; Natalie Timme; Begüm Atasay; Ömer Erdeve; Georg Hansmann; Yogen Singh; Sven C Weber; Elaine L Shelton
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

Review 4.  Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates.

Authors:  Aparna Patra; Pratibha S Thakkar; Majd Makhoul; Henrietta S Bada
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

5.  Editorial: Management of Patent Ductus Arteriosus in Preterm Infants.

Authors:  Begüm Atasay; Ömer Erdeve; Hannes Sallmon; Yogen Singh
Journal:  Front Pediatr       Date:  2021-04-14       Impact factor: 3.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.